CompletedNCT01614093
Oxytocin and Fullness Signals in People With Schizophrenia
About this title
Read the official source — NCT01614093Medication studyAges 18–54United States
Understand this study
Who was this study for?
This study was for people with schizophrenia. Listed age limits: 18 years to 54 years. Other eligibility criteria applied.
- Listed locations
- CatonsvilleSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateJune 2012
- Recruitment status
- Completed
- Enrollment listed in the registry
- 24
- Sponsor
- University of Maryland, Baltimore
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 18 Years to 54 Years
- Official registry ID
- NCT01614093
- Official title
Show the full official title
Effects of Intranasal Oxytocin on Satiety Signaling in People With Schizophrenia
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Catonsville
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of Maryland, Baltimore, a university.
Did this study involve medication?
Yes. The study involved medication, including Oxytocin and Placebo.
Who was this study for?
This study was for people with schizophrenia. Listed age limits: 18 years to 54 years. Other eligibility criteria applied.
